We are live on ! Find out more
CAL

Capital Analysts LLC Portfolio holdings

AUM $4.34B
1-Year Est. Return 17.55%
This Fund
S&P 500
This Quarter Est. Return
+10.34%
1 Year Est. Return
+17.55%
3 Year Est. Return
+51.26%
5 Year Est. Return
+53.67%
10 Year Est. Return
+184.17%
AUM
$1.14B
AUM Growth
+$86.6M
Cap. Flow
-$11.7M
Cap. Flow %
-1.02%
Top 10 Hldgs %
43.01%
Holding
842
New
85
Increased
236
Reduced
205
Closed
102

Sector Composition

Rank Sector Weight
1 Technology 6.49%
2 Healthcare 4.79%
3 Financials 4.08%
4 Industrials 2.93%
5 Consumer Discretionary 2.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNPS icon
101
Synopsys
SNPS
$79.7B
$1.95M 0.17%
7,527
+230
+3% +$53K
BND icon
102
Vanguard Total Bond Market
BND
$161B
$1.95M 0.17%
22,091
+2,557
+13% +$225K
SHW icon
103
Sherwin-Williams
SHW
$89.8B
$1.94M 0.17%
7,938
+165
+2% +$39.1K
SSNC icon
104
SS&C Technologies
SSNC
$18.6B
$1.9M 0.17%
26,078
+1,018
+4% +$68.2K
BAC icon
105
Bank of America
BAC
$442B
$1.89M 0.17%
62,502
+4,723
+8% +$127K
LMBS icon
106
First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF
LMBS
$6.39B
$1.84M 0.16%
35,677
+4,082
+13% +$211K
DHR icon
107
Danaher
DHR
$144B
$1.82M 0.16%
9,219
-2,077
-18% -$416K
EQIX icon
108
Equinix
EQIX
$103B
$1.8M 0.16%
2,525
+78
+3% +$58.1K
MCD icon
109
McDonald's
MCD
$195B
$1.8M 0.16%
8,402
-868
-9% -$189K
AMGN icon
110
Amgen
AMGN
$222B
$1.8M 0.16%
7,815
+434
+6% +$100K
BLK icon
111
Blackrock
BLK
$176B
$1.79M 0.16%
2,482
-417
-14% -$277K
EEMV icon
112
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.56B
$1.77M 0.16%
29,046
-1,492
-5% -$87K
SUM
113
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$1.77M 0.16%
+89,700
New +$1.67M
SDY icon
114
State Street SPDR S&P Dividend ETF
SDY
$22.1B
$1.77M 0.16%
16,667
-344
-2% -$34.8K
ETN icon
115
Eaton
ETN
$174B
$1.75M 0.15%
14,570
-1,901
-12% -$215K
CFG icon
116
Citizens Financial Group
CFG
$30.6B
$1.74M 0.15%
48,684
-4,472
-8% -$140K
SPLK
117
DELISTED
Splunk Inc
SPLK
$1.73M 0.15%
10,206
-981
-9% -$188K
TMO icon
118
Thermo Fisher Scientific
TMO
$220B
$1.72M 0.15%
3,694
-1,035
-22% -$485K
PFE icon
119
Pfizer
PFE
$153B
$1.72M 0.15%
46,700
-5,814
-11% -$213K
FMC icon
120
FMC
FMC
$1.33B
$1.71M 0.15%
14,878
+677
+5% +$75.4K
FISV
121
Fiserv Inc
FISV
$27.9B
$1.71M 0.15%
14,995
+707
+5% +$76.2K
ADI icon
122
Analog Devices
ADI
$190B
$1.7M 0.15%
11,521
-1,417
-11% -$188K
MET icon
123
MetLife
MET
$62.1B
$1.69M 0.15%
35,914
-2,707
-7% -$117K
PAYX icon
124
Paychex
PAYX
$42.7B
$1.69M 0.15%
18,092
-1,751
-9% -$155K
FBT icon
125
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.78B
$1.69M 0.15%
10,033
+45
+0.5% +$7.3K

Similar funds

Capital Analysts LLC's Q4 2020 Portfolio in Review

As of Q4 2020, Capital Analysts LLC held 842 positions worth $1.14B, up 8.2% from $1.05B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Capital Analysts LLC's Q4 2020 filing shows 85 new, 236 increased, 205 reduced and 102 closed positions. Its largest new stake was Xtrackers USD High Yield Corporate Bond ETF: 582,649 shares worth $23.3M. The largest sale was iShares 0-5 Year High Yield Corporate Bond ETF, an estimated $13.7M.

By sector, the portfolio is most concentrated in Technology at 6.5% of assets, down from 7.7% a quarter earlier, followed by Healthcare and Financials.

  • Capital Analysts LLC's largest Q4 2020 buy was Xtrackers USD High Yield Corporate Bond ETF: 582,649 shares worth $23.3M.
  • Capital Analysts LLC added most to Fidelity Low Volatility Factor ETF in Q4 2020, an estimated $5.86M increase.
  • Capital Analysts LLC's biggest Q4 2020 reduction was iShares 0-5 Year High Yield Corporate Bond ETF, cutting an estimated $13.7M.
  • Capital Analysts LLC fully exited State Street SPDR US Large Cap Low Volatility Index ETF in Q4 2020, selling an estimated $6.87M.
  • Capital Analysts LLC's ten largest holdings make up 43% of its $1.14B portfolio in Q4 2020.
  • Capital Analysts LLC opened 85 new positions and closed 102 in Q4 2020.
  • Capital Analysts LLC's portfolio value rose 8.2% quarter-over-quarter to $1.14B.

Based on Capital Analysts LLC's 13F filing for Q4 2020, filed 16 Feb 2021.